Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Prostate cancer is one of the most common cancers affecting men, particularly those over 50. The disease can often grow silently in its early stages, with few obvious symptoms. Because of this, early ...

Former President Joe Biden’s diagnosis of what his office called an “aggressive” form of prostate cancer on Sunday, May 18, is calling attention to a disease that is diagnosed in hundreds of thousands ...

For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...

National guidelines on prostate cancer screening with the PSA test are set by the US Preventive Services Task Force. Marc B. Garnick, the Gorman Brothers Professor of Medicine at Harvard Medical ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Because most of the major risk factors are beyond your control, there’s no proven way to truly reduce ...

Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped around the urethra, as seen in this image taken from Asklepios Atlas of ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

John Eimen, a former child star known for his guest spot in "Leave it to Beaver," died Friday, Nov. 21, a representative ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in ...